Device type · GKA
Abnormal Hemoglobin Quantitation
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
GKA
Hematology
Device class
Class II
FDA decisions since 2015
5
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Abnormal Hemoglobin Quantitation
- Product code
- GKA
- Device class
- Class II
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7415
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for GKA
Latest FDA decisions
K232027 · Decided Apr 4, 2024 · 272 days after receipt
Device type: Abnormal Hemoglobin Quantitation (GKA) · Laboratory Medicine & Pathology
Trinity Biotech (Primus Corporation, Dba Trinity Biotech)
K222635 · Decided Aug 4, 2023 · 338 days after receipt
Device type: Abnormal Hemoglobin Quantitation (GKA) · Laboratory Medicine & Pathology
K192931 · Decided Apr 19, 2022 · 915 days after receipt
Device type: Abnormal Hemoglobin Quantitation (GKA) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Resin UPDATE CD-ROM, REF: 250-3020 inside VARIANTnbs Sickle Cell Program Reorder Pack, REF: 250-3000Open, Classified
Z-1208-2022 · Started Apr 7, 2022
Reason given: The problem is with the Bio-Rad VARIANT nbs Sickle Cell Program Resin Update CD-ROM software; Model Number: 250-3020, included in VARIANT nbs Sickle Cell Progam Reorder Pack #250-3000. This CD-ROM software included in specific lots of VARIANT nbs Sickle Cell Progam Reorder Pack causes all customized settings in the...
Cause as FDA categorized it: Packaging process control
Z-0321-2021 · Started Oct 9, 2020
Reason given: The product did not receive pre-market approval or clearance.
Cause as FDA categorized it: No Marketing Application
Clark Laboratories, Inc. (dba,Trinity Biotech USA)
Z-0620-2019 · Started Nov 1, 2018
Reason given: lack of 510K
Cause as FDA categorized it: No Marketing Application
7 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.